Pregnancy Related Clinical Trial
Official title:
Prenatal Yoga for Pregnancy Related Back Pain
| Verified date | August 2018 |
| Source | Beth Israel Deaconess Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This is a pilot feasibility study investigating prenatal yoga for pregnancy related back pain.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | June 30, 2016 |
| Est. primary completion date | June 30, 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 39 Years |
| Eligibility |
Inclusion Criteria: - uncomplicated pregnancies starting at 12-26 weeks of gestation - pregnant women with and without back pain who had no regular yoga practice. Exclusion Criteria: - significant back pathology - pregnancy complications - non-English speaking - otherwise were not able to participate (eg. transportation, scheduling issues) |
| Country | Name | City | State |
|---|---|---|---|
| United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| Beth Israel Deaconess Medical Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | feasibility of recruitment | recruitment rate | baseline | |
| Secondary | back pain disability | Roland Morris Disability Questionnaire (range 0-24), lower better | baseline, 4, 8, 12 weeks | |
| Secondary | back pain severity | Back Pain Severity Visual Analogue Scale (rage 0-10), lower better | baseline, 4, 8, 12 weeks | |
| Secondary | pregnancy symptoms | Pregnancy Symptom Inventory (range 0-123), lower better | baseline, 4, 8, 12 weeks | |
| Secondary | depression | Edinburgh Postnatal Depression Scale (range 0-30), lower better | baseline, 4, 8, 12 weeks | |
| Secondary | quality of lfe | Short Form-12 (range 12-56), higher better | baseline, 4, 8, 12 weeks | |
| Secondary | childbirth experience | Childbirth Experience (range 19-76), higher better | postpartum visit | |
| Secondary | mobility lab- speed | instrumented gait speed | baseline, 4, 8, 12 weeks | |
| Secondary | acceptability | class attendance | 4,8, 12 weeks, postpartum | |
| Secondary | mobility lab- double support | double support time | baseline, 4, 8, 12 weeks | |
| Secondary | mobility lab- TUG | timed up and go time | baseline, 4, 8, 12 weeks | |
| Secondary | mobility lab- turn | turn time | baseline, 4, 8, 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
| Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
| Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
| Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
| Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
| Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
| Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
| Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
| Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
| Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
| Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
| Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
| Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
| Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
| Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
| Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
| Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
| Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |